Creation of infectious disease treatment platform by novel nucleic acid therapeutics with remarkably enhanced catalytic target RNA cleavage activities
- Funded by Japan Agency for Medical Research and Development (AMED)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Funder
Japan Agency for Medical Research and Development (AMED)Principal Investigator
Professor Takehiko WADAResearch Location
JapanLead Research Institution
Institute of Multidisciplinary Research for Advanced Materials Professor, Tohoku UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable